Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-20-002868

Chief Executive Officer bought 14,071,856 shares at $3.34 ($46,999,999)

From the SEC's structured data for this filing

Trades in this filing

DUGGAN ROBERT W · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-06 Purchase : show line 1 in the form +14,071,856 $3.34 $46,999,999 56,296,533 D
Open-market purchases · 14,071,856 sh · avg $3.34 · $46,999,999
Loading xslF345X03/form412566001_11102020.xml…